As of 2025-03-23, the Relative Valuation of Relay Therapeutics Inc (RLAY) is (53.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.06 USD, the upside of Relay Therapeutics Inc based on Relative Valuation is -1852.9%.
The range of the Relative Valuation is (42.51) - (61.36) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 21.3x - 36.5x | 28.9x |
| Forward P/E multiples | 19.1x - 30.8x | 25.0x |
| Fair Price | (42.51) - (61.36) | (53.64) |
| Upside | -1489.3% - -2105.2% | -1852.9% |
| Date | P/E |